Physician Wealth Advisors’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.5K Buy
664
+210
+46% +$3.25K ﹤0.01% 863
2026
Q1
$6.13K Buy
454
+18
+4% +$252 ﹤0.01% 938
2025
Q4
$5.42K Buy
436
+1
+0.2% +$11 ﹤0.01% 954
2025
Q3
$4.31K Buy
435
+160
+58% +$1.56K ﹤0.01% 965
2025
Q2
$2.46K Sell
275
-98
-26% -$829 ﹤0.01% 976
2025
Q1
$3.25K Buy
373
+104
+39% +$1.09K ﹤0.01% 801
2024
Q4
$3.35K Buy
+269
New +$3.31K ﹤0.01% 788

Other funds holding VTRS

Physician Wealth Advisors's VTRS Position: Q2 2026 in Review

Physician Wealth Advisors increased its Viatris (VTRS) stake by 46% in Q2 2026, buying an estimated $3.25K and bringing the position to 664 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #863.

Physician Wealth Advisors first reported a position in VTRS in Q4 2024 and has held it in 7 quarters since. 216 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Physician Wealth Advisors held 664 shares of Viatris worth $10.5K as of Q2 2026.
  • Physician Wealth Advisors bought 210 Viatris shares in Q2 2026, an estimated $3.25K.
  • Viatris made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #863 holding.
  • Physician Wealth Advisors first reported a position in Viatris in Q4 2024 and has held it in 7 quarters since.
  • 216 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.